Larimar Therapeutics
LRMR
116 hedge funds and large institutions have $245M invested in Larimar Therapeutics in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 32 reducing their positions, and 27 closing their positions.
432% more call options, than puts
Call options by funds: $2.13M | Put options by funds: $400K
38% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 32
1.4% less ownership
Funds ownership: 100.81% → 99.41% (-1.4%)
6% less funds holding
Funds holding: 123 → 116 (-7)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
42% less capital invested
Capital invested by funds: $421M → $245M (-$176M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$5.79M |
| 2 |
BOCH
Blue Owl Capital Holdings
New York
|
+$3.21M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.63M |
| 4 |
BlackRock
New York
|
+$1.93M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$4.11M |
| 2 |
Millennium Management
New York
|
-$3.36M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.19M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.59M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.57M |
LRMR Hedge Fund Activity: Q4 2024 in Review
116 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Larimar Therapeutics (LRMR) for Q4 2024, worth a combined $245M — down 42% from $421M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of LRMR and 22 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 44 added.
The largest buyer was Janus Henderson Group, adding an estimated $5.79M. The largest seller was Woodline Partners, cutting an estimated $4.11M.
- 116 institutional investors held Larimar Therapeutics (LRMR) as of Q4 2024, down from 123 in Q3 2024.
- Funds reported $245M of Larimar Therapeutics stock for Q4 2024, down 42% quarter-over-quarter.
- 22 funds opened new Larimar Therapeutics positions in Q4 2024 and 27 closed out, a net change of -5 holders.
- The largest Larimar Therapeutics buyer in Q4 2024 was Janus Henderson Group, an estimated $5.79M added.
- The largest Larimar Therapeutics seller in Q4 2024 was Woodline Partners, an estimated $4.11M sold.
Based on aggregated 13F filings for Q4 2024.